RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price traded up 0.7% during trading on Monday . The company traded as high as GBX 1.54 ($0.02) and last traded at GBX 1.53 ($0.02). 445,633 shares were traded during trading, a decline of 14% from the average session volume of 516,426 shares. The stock had previously closed at GBX 1.52 ($0.02).
RTW Biotech Opportunities Stock Performance
The company has a market cap of £5.88 million, a price-to-earnings ratio of 4.25 and a beta of 0.60. The business has a fifty day moving average price of GBX 1.56 and a 200 day moving average price of GBX 1.44.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Stories
- Five stocks we like better than RTW Biotech Opportunities
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Investing in Construction Stocks
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.